Successful second autologous blood stem cell transplantation after G-CSF-combined conditioning for the treatment of high-risk acute myelogenous leukemia

Y. Takamatsu, T. Teshima, Koichi Akashi, S. Inaba, M. Harada, Y. Niho

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We describe a patient with acute myelogenous leukemia (AML) who received his second autologous blood stem cell transplantation (ABSCT) following a G-CSF-combined pre-transplant conditioning regimen. The patient underwent ABSCT during first remission but suffered a relapse 8 months later. After achieving second remission, he was prepared for his second ABSCT; recombinant human granulocyte colony-stimulating factor (rhG-CSF) was administered in combination with Ara C, in addition to the same conditioning regimen as that used before the first ABSCT. There was no increase in regimen-related toxicity after this second G-CSF-combined conditioning regimen when compared with that observed after the first ABSCT. To date, the patient's second remission following the second ABSCT has lasted 26 months, which has exceeded that following the first ABSCT. The G-CSF-combined pretransplant conditioning regimen for ABSCT may be effective in the treatment of high-risk AML by increasing the chemosensitivity of the residual leukemic cells.

Original languageEnglish
Pages (from-to)325-327
Number of pages3
JournalBone Marrow Transplantation
Volume13
Issue number3
Publication statusPublished - Jan 1 1994
Externally publishedYes

Fingerprint

Stem Cell Transplantation
Granulocyte Colony-Stimulating Factor
Acute Myeloid Leukemia
Blood Cells
Therapeutics
Cytarabine
Transplants
Recurrence

All Science Journal Classification (ASJC) codes

  • Hematology
  • Transplantation

Cite this

Successful second autologous blood stem cell transplantation after G-CSF-combined conditioning for the treatment of high-risk acute myelogenous leukemia. / Takamatsu, Y.; Teshima, T.; Akashi, Koichi; Inaba, S.; Harada, M.; Niho, Y.

In: Bone Marrow Transplantation, Vol. 13, No. 3, 01.01.1994, p. 325-327.

Research output: Contribution to journalArticle

@article{ed4622ab00f04b56bc6ec92333cacda8,
title = "Successful second autologous blood stem cell transplantation after G-CSF-combined conditioning for the treatment of high-risk acute myelogenous leukemia",
abstract = "We describe a patient with acute myelogenous leukemia (AML) who received his second autologous blood stem cell transplantation (ABSCT) following a G-CSF-combined pre-transplant conditioning regimen. The patient underwent ABSCT during first remission but suffered a relapse 8 months later. After achieving second remission, he was prepared for his second ABSCT; recombinant human granulocyte colony-stimulating factor (rhG-CSF) was administered in combination with Ara C, in addition to the same conditioning regimen as that used before the first ABSCT. There was no increase in regimen-related toxicity after this second G-CSF-combined conditioning regimen when compared with that observed after the first ABSCT. To date, the patient's second remission following the second ABSCT has lasted 26 months, which has exceeded that following the first ABSCT. The G-CSF-combined pretransplant conditioning regimen for ABSCT may be effective in the treatment of high-risk AML by increasing the chemosensitivity of the residual leukemic cells.",
author = "Y. Takamatsu and T. Teshima and Koichi Akashi and S. Inaba and M. Harada and Y. Niho",
year = "1994",
month = "1",
day = "1",
language = "English",
volume = "13",
pages = "325--327",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Successful second autologous blood stem cell transplantation after G-CSF-combined conditioning for the treatment of high-risk acute myelogenous leukemia

AU - Takamatsu, Y.

AU - Teshima, T.

AU - Akashi, Koichi

AU - Inaba, S.

AU - Harada, M.

AU - Niho, Y.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - We describe a patient with acute myelogenous leukemia (AML) who received his second autologous blood stem cell transplantation (ABSCT) following a G-CSF-combined pre-transplant conditioning regimen. The patient underwent ABSCT during first remission but suffered a relapse 8 months later. After achieving second remission, he was prepared for his second ABSCT; recombinant human granulocyte colony-stimulating factor (rhG-CSF) was administered in combination with Ara C, in addition to the same conditioning regimen as that used before the first ABSCT. There was no increase in regimen-related toxicity after this second G-CSF-combined conditioning regimen when compared with that observed after the first ABSCT. To date, the patient's second remission following the second ABSCT has lasted 26 months, which has exceeded that following the first ABSCT. The G-CSF-combined pretransplant conditioning regimen for ABSCT may be effective in the treatment of high-risk AML by increasing the chemosensitivity of the residual leukemic cells.

AB - We describe a patient with acute myelogenous leukemia (AML) who received his second autologous blood stem cell transplantation (ABSCT) following a G-CSF-combined pre-transplant conditioning regimen. The patient underwent ABSCT during first remission but suffered a relapse 8 months later. After achieving second remission, he was prepared for his second ABSCT; recombinant human granulocyte colony-stimulating factor (rhG-CSF) was administered in combination with Ara C, in addition to the same conditioning regimen as that used before the first ABSCT. There was no increase in regimen-related toxicity after this second G-CSF-combined conditioning regimen when compared with that observed after the first ABSCT. To date, the patient's second remission following the second ABSCT has lasted 26 months, which has exceeded that following the first ABSCT. The G-CSF-combined pretransplant conditioning regimen for ABSCT may be effective in the treatment of high-risk AML by increasing the chemosensitivity of the residual leukemic cells.

UR - http://www.scopus.com/inward/record.url?scp=0028082202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028082202&partnerID=8YFLogxK

M3 - Article

C2 - 7515302

AN - SCOPUS:0028082202

VL - 13

SP - 325

EP - 327

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 3

ER -